/
The NOSI™ : an innovative prosthetic treatment option for The NOSI™ : an innovative prosthetic treatment option for

The NOSI™ : an innovative prosthetic treatment option for - PowerPoint Presentation

min-jolicoeur
min-jolicoeur . @min-jolicoeur
Follow
423 views
Uploaded On 2017-06-19

The NOSI™ : an innovative prosthetic treatment option for - PPT Presentation

Ginette Phippen DClinP MRCSLT Paul Grew MIMP amp Mark Richards MIMP The Spires Cleft Centre Oxford amp Salisbury Salisbury Oral amp Maxillofacial Lab ID: 560953

nosi amp salisbury cleft amp nosi cleft salisbury speech spires oxford centre trial nasal small medical oral patients phase

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "The NOSI™ : an innovative prosthetic t..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

The NOSI™ : an innovative prosthetic treatment option for nasal speech associated with velopharyngeal dysfunction.

Ginette Phippen DClinP, MRCSLT, Paul Grew MIMP & Mark Richards MIMPThe Spires Cleft Centre (Oxford & Salisbury)Salisbury Oral & Maxillofacial Lab

Salisbury NHS Foundation TrustSlide2

Causes of VPD (& nasal speech)

Structural Mechanical Neurogenic Mislearning

The Spires Cleft Centre, Oxford & SalisburySlide3

Treatment optionsSurgery (+/- speech therapy)Clear structural defectSpeech therapyMislearned/compensatory sounds

ProstheticsSurgery contraindicatedPrevious unsuccessful surgeryNo intervention

The Spires Cleft Centre, Oxford & SalisburySlide4

Non-surgical interventions for nasal speech?Palatal prosthetics is an option for some but requires

a high level of commitment and resources.Could a nasal obturator offer an immediate, acceptable and low burden option for some patients?

The Spires Cleft Centre, Oxford & SalisburySlide5

Development processFrom this…… To this……

The Spires Cleft Centre, Oxford & SalisburySlide6

The Idea: Phase 1 (2014-15)

Suwaki

et al (2008)case study: nasal speaking valve

Literature search: 1additional case study;

Hakel et al 2004, one-way valve

Product search – nasal filters

Innovative valve design by maxillofacial technicians at Salisbury District Hospital

The Spires Cleft Centre, Oxford & SalisburySlide7

Developing the idea – Phase 1 (2014-15)

Trademark application/design rights/patenting

3d printing

Prosthesis prototypes

Advice from Trust Innovation Lead

Support & Funding from Spires Board

Poster CFSGBI conference (April 2014)

Contact with medical device manufacturers

The Spires Cleft Centre, Oxford & SalisburySlide8

Progress

Challenges

Positive response to preliminary development from patients and specialist centres

Valuable feedback from patients to inform design

Support from Innovation Lead

Funding from Spires Charitable Fund for development

Interest from medical device manufacturers

Making progress with development in a busy clinical service

Provision of replacement devices

Support from Innovation Lead

Evaluating acceptability and function

Progressing from prototype to low volume manufacture

Phase 1

The Spires Cleft Centre, Oxford & SalisburySlide9

Developing the idea – Phase 2 (2015-16)

Field testing with 19 patients; including assessment of acceptability and effect on speech

UK cleft centres signed up to test with patients…..

Small number of devices made at SDH

Potential manufacturer/commercial partner identified

The Spires Cleft Centre, Oxford & SalisburySlide10

Prototype field testingQuestion:Is the NOSI™ acceptable and functional for individuals with nasal speech associated with VPD?

The Spires Cleft Centre, Oxford & SalisburySlide11

Field testing

The Spires Cleft Centre, Oxford & SalisburySlide12

Evaluating acceptability

The Spires Cleft Centre, Oxford & Salisbury

1.

Does your speech sound different when you use

the NOSI

?

Yes

Don’t

know

No

H

ow

does it sound to you?

_________________________________________________________________

2.

Are you

happy to use the

NOSI

?

Yes

Sometimes

No

H

ave

you

used it…. at home

?

at

school

?

on the phone

?

3.

Do you like how the

NOSI looks

?

Yes

Not sure

No

4.

Would you

tell another child

/young person

to try the NOSI?

Yes

Maybe

No

Is there a

ny

thi

ng else you want to tell us about the NOSI

?

Slide13

Evaluating effect on speechGOS.SP.ASS Perceptual rating of resonance and audible nasal emission? Nasometry

Patient reported effect (descriptive)The Spires Cleft Centre, Oxford & SalisburySlide14

Patient

Age

Diagnosis

OX or SALS

Outcome

Status

A

21

TBI

OX

M NOSI trial at home & speech therapy

In use

B

19

TBI

OX

M NOSI trial at home & speech therapy

In use

C

13

22q11ds

OX

M NOSI for use in speech therapy at school

In use

D

51

CVA

OX

M NOSI trial at home & speech therapy

In use

E

31

Cleft Palate

OX

M NOSI trial at home

In use

F

14

Cleft Palate

OX

M NOSI trial at home & speech therapy

Waiting

G

6.9

Non-cleft VPD

OX

X-Small NOSI

Waiting

H

10

Congenital Myopathy

OX

Bespoke NOSI, one x-small nostril

Waiting

I

10

22q11ds

OX

X-Small NOSI

Waiting

J

60

Post-surg VPD

SALS

L NOSI and palatal obturator

Waiting

K

65

Post-surg VPD

SALS

L NOSI

Waiting

L

8

Cleft Palate

SALS

S NOSI

Waiting

M

28

TBI

OX

M NOSI

Discontinued

N

10

NF1

SALS

Bespoke NOSI trial at home

Discontinued

O

4.8

Worster Drought

SALS

On hold

Discontinued

P

4.11

Non-cleft VPD

SALS

S NOSI

Discontinued

Q

52

Non-cleft VPD

SALS

Bespoke NOSI trial at home

Discontinued

R

19

Worster Drought

SALS

L NOSI trial at home

Discontinued  

S

49

CVA

SALS

L NOSI trial at home

Discontinued

The Spires Cleft Centre, Oxford & SalisburySlide15

The Spires Cleft Centre, Oxford & Salisbury

Pt

Age

Diagnosis

OX or SALS

Outcome

Subjective Evaluation

A

21

TBI

OX

M NOSI trial at home & speech therapy

speech effort

? facilitated voice

B

19

TBI

OX

M NOSI trial at home & speech therapy

hypernasality

speech effort

C

13

22q11ds

OX

M NOSI for speech therapy at school

Facilitated oral consonant placement

D

51

CVA

OX

M NOSI trial at home & speech therapy

hypernasality

speech effort

E

31

Cleft Palate

OX

M NOSI trial at home

audible nasal

emission

In UseSlide16

The Spires Cleft Centre, Oxford & Salisbury

Pt

Age

Diagnosis

OX or SALS

Outcome

Evaluation (interim)

F

14

Cleft Palate

OX

M NOSI trial at home & speech therapy

 hypernasality

Facilitated oral consonant placement

G

6.9

Non-cleft VPD

OX

XS NOSI

Facilitated oral consonant placement

H

10

Congenital Myopathy

OX

Bespoke NOSI, one x-small nostril

 Speech effort

I

10

22q11ds

OX

XS NOSI

?????

J

60

Post-surg VPD

SALS

L NOSI and palatal obturator

hypernasality

ANE

K

65

Post-surg VPD

SALS

L NOSI

hypernasality

ANE

L

8

Cleft Palate

SALS

S NOSI

hypernasality

ANE

WaitingSlide17

The Spires Cleft Centre, Oxford & Salisbury

Patient

Age

Diagnosis

OX or SALS

Outcome

Evaluation

M

28

TBI

OX

M NOSI

Not independent

Robotic surgery

N

10

NF1

SALS

Bespoke NOSI trial at home

Low impact of VPI

O

4.8

Worster Drought

SALS

On hold

Resistant to introduction

Try later

P

8

Non-cleft VPD

SALS

S NOSI

Candidate for palatal prosthesis

Q

52

Non-cleft VPD

SALS

Bespoke NOSI trial at home

Candidate for surgery

R

19

Worster Drought

SALS

L NOSI trial at home

Unhappy with appearance

S

49

CVA

SALS

L NOSI trial at home

Unhappy with appearance

DiscontinuedSlide18

Next steps?The Spires Cleft Centre, Oxford & SalisburySlide19

Development process – Phase 2 (2016)

Medical technology company discussions

Prototype 2 prosthesis completed (Injection

moulding)

Further field testing with 12 patients and other

cleft centres/SLT depts

Class 1 Medical Device/CE marking

Commercialisation process

Formal evaluation

The Spires Cleft Centre, Oxford & SalisburySlide20

Prototype 2 The Spires Cleft Centre, Oxford & SalisburySlide21

Thank youFor more information please contact: Ginette Phippen

gphippen@nhs.net01722 345571

REFERENCES

Suwaki, M., Nanba, K., Ito, E., Kumakura, I., Minagi, S. (2008) The effect of nasal speakingvalve on the speech under experimental

incompetence condition. Journal of Oral Rehabilitation, May, 35/5, 361-9Hakel, M., Beukelman, D,R., Fager, S., Green, J.,Marshall, J. (2004) Nasal obturator for velopharyngeal dysfunction in dysarthria:

Technical report on a one-way valve.

Journal of Medical Speech-Language Pathology

, December,12/4, 155-9.

Sell, D., Harding, A. & Grunwell, P. (1999). GOS.SP.ASS'98: an assessment for speech disorders associated with cleft palate and / or velopharyngeal dysfunction (revised). Int. J. Language & Communication Disorders, 34(1), 17-33.

©NOSI™ 2014

WWW.SPIRESCLEFTCENTRE.NHS.UK

The Spires Cleft Centre, Oxford & Salisbury